IFNG and neoplasm: Given binding of PD-L1 to PD-1 interferes with the anti-tumor response and proliferation of T cells, especially CD8+ subpopulations51, we next assessed the level of tumor-specific interferon-γ (IFNγ) in CD8+ tumor-infiltrating lymphocytes52.